155 related articles for article (PubMed ID: 37373509)
1. The Effect of CacyBP/SIP on the Phosphorylation of ERK1/2 and p38 Kinases in Clear Cell Renal Cell Carcinoma.
Smereczańska M; Domian N; Młynarczyk G; Kasacka I
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373509
[TBL] [Abstract][Full Text] [Related]
2. MAP kinase p38 is a novel target of CacyBP/SIP phosphatase.
Topolska-Woś AM; Rosińska S; Filipek A
Amino Acids; 2017 Jun; 49(6):1069-1076. PubMed ID: 28283909
[TBL] [Abstract][Full Text] [Related]
3. ERK1/2 is dephosphorylated by a novel phosphatase--CacyBP/SIP.
Kilanczyk E; Filipek S; Filipek A
Biochem Biophys Res Commun; 2011 Jan; 404(1):179-83. PubMed ID: 21110948
[TBL] [Abstract][Full Text] [Related]
4. Comparative Assessment of the WNT/β-Catenin Pathway, CacyBP/SIP, and the Immunoproteasome Subunit LMP7 in Various Histological Types of Renal Cell Carcinoma.
Piotrowska Ż; Niezgoda M; Młynarczyk G; Acewicz M; Kasacka I
Front Oncol; 2020; 10():566637. PubMed ID: 33330038
[TBL] [Abstract][Full Text] [Related]
5. CacyBP/SIP in the rat spinal cord in norm and after transection - Influence on the phosphorylation state of ERK1/2 and p38 kinases.
Jurewicz E; Miazga K; Fabczak H; Sławińska U; Filipek A
Neurochem Int; 2020 Sep; 138():104757. PubMed ID: 32544715
[TBL] [Abstract][Full Text] [Related]
6. CacyBP/SIP phosphatase activity in neuroblastoma NB2a and colon cancer HCT116 cells.
Kilanczyk E; Wasik U; Filipek A
Biochem Cell Biol; 2012 Aug; 90(4):558-64. PubMed ID: 22480271
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Expression and Localization of the Multifunctional Protein CacyBP/SIP and Elements of the MAPK Signaling Pathway in the Adrenal Glands of Rats with Primary and Secondary Hypertension.
Smereczańska M; Domian N; Młynarczyk M; Pędzińska-Betiuk A; Kasacka I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203261
[TBL] [Abstract][Full Text] [Related]
8. Distinct effect of CacyBP/SIP on the ERK1/2-CREB-BDNF pathway in undifferentiated and differentiated neuroblastoma NB2a cells.
Rosińska S; Leśniak W; Filipek A
Neurochem Int; 2016 Jul; 97():65-72. PubMed ID: 27180052
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma.
Sun S; Ning X; Liu J; Liu L; Chen Y; Han S; Zhang Y; Liang J; Wu K; Fan D
Biochem Biophys Res Commun; 2007 May; 356(4):864-71. PubMed ID: 17400182
[TBL] [Abstract][Full Text] [Related]
10. Dimerization and phosphatase activity of calcyclin-binding protein/Siah-1 interacting protein: the influence of oxidative stress.
Topolska-Woś AM; Shell SM; Kilańczyk E; Szczepanowski RH; Chazin WJ; Filipek A
FASEB J; 2015 May; 29(5):1711-24. PubMed ID: 25609429
[TBL] [Abstract][Full Text] [Related]
11. CacyBP/SIP binds ERK1/2 and affects transcriptional activity of Elk-1.
Kilanczyk E; Filipek S; Jastrzebska B; Filipek A
Biochem Biophys Res Commun; 2009 Feb; 380(1):54-9. PubMed ID: 19166809
[TBL] [Abstract][Full Text] [Related]
12. Influence of S100A6 on CacyBP/SIP Phosphorylation and Elk-1 Transcriptional Activity in Neuroblastoma NB2a Cells.
Wasik U; Kadziolka B; Kilanczyk E; Filipek A
J Cell Biochem; 2016 Jan; 117(1):126-31. PubMed ID: 26085436
[TBL] [Abstract][Full Text] [Related]
13. CacyBP/SIP inhibits Doxourbicin-induced apoptosis of glioma cells due to activation of ERK1/2.
Tang Y; Zhan W; Cao T; Tang T; Gao Y; Qiu Z; Fu C; Qian F; Yu R; Shi H
IUBMB Life; 2016 Mar; 68(3):211-9. PubMed ID: 26825673
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle-dependent translocation and regulatory mechanism of CacyBP/SIP in gastric cancer cells.
Chen Y; Zhang K; Wang X; Li Q; Wu Q; Ning X
Anticancer Drugs; 2018 Jan; 29(1):19-28. PubMed ID: 29099417
[TBL] [Abstract][Full Text] [Related]
15. The CacyBP/SIP protein is sumoylated in neuroblastoma NB2a cells.
Wasik U; Filipek A
Neurochem Res; 2013 Nov; 38(11):2427-32. PubMed ID: 24078263
[TBL] [Abstract][Full Text] [Related]
16. CacyBP/SIP--Structure and variety of functions.
Topolska-Woś AM; Chazin WJ; Filipek A
Biochim Biophys Acta; 2016 Jan; 1860(1 Pt A):79-85. PubMed ID: 26493724
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CacyBP/SIP expression by NFAT1 transcription factor.
Kądziołka B; Leśniak W; Filipek A
Immunobiology; 2017 Aug; 222(8-9):872-877. PubMed ID: 28526484
[TBL] [Abstract][Full Text] [Related]
18. CacyBP/SIP expression is involved in the clinical progression of breast cancer.
Wang N; Ma Q; Wang Y; Ma G; Zhai H
World J Surg; 2010 Nov; 34(11):2545-52. PubMed ID: 20585948
[TBL] [Abstract][Full Text] [Related]
19. CacyBP/SIP nuclear translocation regulates p27Kip1 stability in gastric cancer cells.
Niu YL; Li YJ; Wang JB; Lu YY; Liu ZX; Feng SS; Hu JG; Zhai HH
World J Gastroenterol; 2016 Apr; 22(15):3992-4001. PubMed ID: 27099442
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in distribution of cannabinoid receptors (CB1 and CB2), S100A6 and CacyBP/SIP in human ageing hearts.
Piotrowska Ż; Niezgoda M; Łebkowski W; Filipek A; Domian N; Kasacka I
Biol Sex Differ; 2018 Nov; 9(1):50. PubMed ID: 30482253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
